PT - JOURNAL ARTICLE AU - Firth, Josh A. AU - Hellewell, Joel AU - Klepac, Petra AU - Kissler, Stephen AU - CMMID COVID-19 working group AU - Kucharski, Adam AU - Spurgin, Lewis G. TI - Combining fine-scale social contact data with epidemic modelling reveals interactions between contact tracing, quarantine, testing and physical distancing for controlling COVID-19 AID - 10.1101/2020.05.26.20113720 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.26.20113720 4099 - http://medrxiv.org/content/early/2020/05/27/2020.05.26.20113720.short 4100 - http://medrxiv.org/content/early/2020/05/27/2020.05.26.20113720.full AB - Case isolation and contact tracing can contribute to the control of COVID-19 outbreaks. However, it remains unclear how real-world networks could influence the effectiveness and efficiency of such approaches. To address this issue, we simulated control strategies for SARS-CoV-2 in a real-world social network generated from high resolution GPS data. We found that tracing contacts-of-contacts reduced the size of simulated outbreaks more than tracing of only contacts, but resulted in almost one third of the local population being quarantined at a single point in time. Testing and releasing non-infectious individuals reduced the numbers of quarantined individuals without large increases in outbreak size, but high testing rates were required for this to be effective. Finally, if testing availability is constrained, we estimated that combining physical distancing with contact tracing could enable epidemic control while reducing the number of quarantined individuals. Our approach highlights the importance of network structure and social dynamics in evaluating the potential impact of SARS-CoV-2 control.Competing Interest StatementThe authors have declared no competing interest.Funding StatementJAF was supported by a research fellowship from Merton College and BBSRC (BB/S009752/1) and acknowledges funding from NERC (NE/S010335/1). PK was in part funded by the Royal Society under award RP\EA\180004 and European Commission: 101003688. AJK was supported by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (grant Number 206250/Z/17/Z).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Information was provided and consent obtained from all participants in the study before the app recorded any data. The study was approved by London School of Hygiene & Tropical Medicine Observational Research Ethics Committee (ref 14400).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThis study used the raw data previously published in Kissler et al. 2018 (made available with full description here: https://www.biorxiv.org/content/10.1101/479154v1) The code and data used to produce the simulations is available as an R package at: https://github.com/biouea/covidhm A shiny app which runs individual outbreak simulations is available at: https://biouea.shinyapps.io/covidhm_shiny/ https://github.com/biouea/covidhm